2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol

C27H26N8O2 — CID 166927670

IUPAC2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol
SMILESCc1cc(Nc2ncnc3cnc(N4CC5(CC(O)C5)C4)nc23)ccc1Oc1ccc2c(c1)ncn2C
InChIInChI=1S/C27H26N8O2/c1-16-7-17(3-6-23(16)37-19-4-5-22-20(8-19)31-15-34(22)2)32-25-24-21(29-14-30-25)11-28-26(33-24)35-12-27(13-35)9-18(36)10-27/h3-8,11,14-15,18,36H,9-10,12-13H2,1-2H3,(H,29,30,32)
InChIKeyPHHSCGQMDFOMLC-UHFFFAOYSA-N
MW494.56 g/mol
LogP4.11
Rot. Bonds5

About 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol

2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol (PubChem CID 166927670) has the molecular formula C27H26N8O2 and a molecular weight of 494.56 g/mol. Its IUPAC name is 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol.

Molecular Properties

Compound Name2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol
PubChem CID166927670
Molecular FormulaC27H26N8O2
Molecular Weight494.56 g/mol
Exact Mass494.22
IUPAC Name2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol
SMILESCc1cc(Nc2ncnc3cnc(N4CC5(CC(O)C5)C4)nc23)ccc1Oc1ccc2c(c1)ncn2C
InChIInChI=1S/C27H26N8O2/c1-16-7-17(3-6-23(16)37-19-4-5-22-20(8-19)31-15-34(22)2)32-25-24-21(29-14-30-25)11-28-26(33-24)35-12-27(13-35)9-18(36)10-27/h3-8,11,14-15,18,36H,9-10,12-13H2,1-2H3,(H,29,30,32)
InChIKeyPHHSCGQMDFOMLC-UHFFFAOYSA-N
XLogP4.11
TPSA114.11 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds5
Heavy Atoms37
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500494.56
LogP ≤ 54.11
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol?
The IUPAC name of 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol (CID 166927670) is 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol.
What is the SMILES notation for 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol?
The canonical SMILES for 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol is Cc1cc(Nc2ncnc3cnc(N4CC5(CC(O)C5)C4)nc23)ccc1Oc1ccc2c(c1)ncn2C.
What is the InChIKey of 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol?
The InChIKey is PHHSCGQMDFOMLC-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26N8O2/c1-16-7-17(3-6-23(16)37-19-4-5-22-20(8-19)31-15-34(22)2)32-25-24-21(29-14-30-25)11-28-26(33-24)35-12-27(13-35)9-18(36)10-27/h3-8,11,14-15,18,36H,9-10,12-13H2,1-2H3,(H,29,30,32).
What are the key properties of 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol?
2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol has a molecular weight of 494.56 g/mol, XLogP of 4.11, 5 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[3-methyl-4-(1-methylbenzimidazol-5-yl)oxyanilino]pyrimido[5,4-d]pyrimidin-6-yl]-2-azaspiro[3.3]heptan-6-ol is sourced from PubChem (CID 166927670), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).